novo nordisk semaglutide clinical trials New Wegovy trial finds surprising benefits that go way beyond weight loss Novo Nordisk shares slide after

doi: 10.16250/j.32.1374.2019252 184 HesseMModolellMLa FlammeACSchitoMFuentesJMCheeverAWet al

For the full scientific overview, see What Is Semaglutide

Some studies have explored whether GLP-1 RAs could be used as a standalone treatment or in combination with other therapies for depression

Medical Obesity Treatment Options Currently there are 10 FDA-approved anti-obesity medications in the US: phentermine, diethylpropion, benzphetamine, phendimetrazine, orlistat, phentermine/topiramate ER (Qsymia), bupropion/naltrexone (Contrave), liraglutide (Saxenda), setmelanotide (Imcivree), and now semaglutide (Wegovy and Ozempic)

GLP-1 medications are a tool, but they are not the foundation of long-term health

While individual results vary, many of our Long Beach patients begin to see noticeable changes within the first few weeks of starting their program